v ::INDO AMERICAN JOURNAL OF PHARMACEUTICAL SCIENCES::
ResearcherID - CLICK HERE Scientific Journal Impact Factor (SJIF-2020) - CLICK HERE

TITLE:

RAISED HOMOCYSTEINE LEVEL IN CASES WITH ISCHEMIC STROKE

AUTHORS:

Dr. Iqra Zahid, Dr. Hira Khalid, Dr. Javeria Khalid

ABSTRACT:

Stroke remains one of the most devastating of all neurological diseases, often causing death or gross physical impairment or disability. Homocysteine is one of the modifiable risk factor regarding this. Objectives: To determine the frequency of raised homocysteine level in patients of ischemic stroke. Material and methods: This was a cross sectional study that was conducted at Emergency Departments of Continental medical college Lahore, Allama Iqbal Medical college, Lahore and Islam Medical college Sialkot during July to December 2019 in which 146 cases with age range of 40 to 70 years of both gender suffering from ischemic stroke were included and were assessed for their homocysteine level Results: In this study there were 146 cases out of which 76 (52.05%) were males and 70 (47.95%) females. The mean age was 56.25± 7.67 years and mean BMI was 29.52± 3.42. There were 40 (27.40%) cases with DM, 48 (32.88%) hypertensive, 46 (31.51%) had history of smoking while 18 (12.33%) had family history of ischemic stroke. Raised homocysteine level was seen in 58 (33.70%) cases. Raised homocysteine level was more seen in females where it was seen in 32 (45.71%) out of 70 females as compared to 26 (34.21%) out of 76 males with p values of 0.32. This raised level was also seen maximum in age groups of 60 to 70 years affecting 28 (45.14%) out of 62 cases (p=0.43). There was no significant association with any of the risk factors with raised homocysteine level. Conclusion: Ischemic stroke is a fatal condition. Raised homocysteine level is seen in every 3rd cases of ischemic stroke. Hypertension and family history of ischemic stroke has almost significant association with it. Key words: Stroke, homocysteine.

FULL TEXT

<
Top
  • Follows us on
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.